Article info

Download PDFPDF

Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis

Authors

  1. Correspondence to Professor Christopher P Denton, University College London Division of Medicine, Royal Free Campus, London, NW3 2PF, UK; c.denton{at}ucl.ac.uk
View Full Text

Citation

Denton CP, Ong VH, Xu S, et al
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis

Publication history

  • Received January 16, 2018
  • Revised April 23, 2018
  • Accepted April 25, 2018
  • First published May 31, 2018.
Online issue publication 
August 10, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.